Table 3.
Multivariate Cox regression analysis to estimate the influence of GPS and clinicopathological parameters on the OS and DFS
| preT | p value | HR | 95% CI |
|---|---|---|---|
| OS | |||
| preT-albumin (≥35.0 g/L vs. <35.0 g/L) | 0.05 | 0.53 | 0.31–0.85 |
| Grading (G2 vs. G3) | 0.01** | 0.48 | 0.33–0.77 |
| mGPS (1+2 vs. 0) | 0.015 | 1.76 | 1.10–2.87 |
| DFS | |||
| preT-albumin (≥35.0 g/L vs. <35.0 g/L) | 0.03 | 0.51 | 0.33–0.80 |
| T-stages (pT2 vs. pT3) | 0.05 | 0.57 | 0.35–0.87 |
| mGPS (0 vs. 1+2) | 0.019 | 1.66 | 1.11–2.53 |
DFS, disease-free survival; OS, overall survival; mGPS, modified Glasgow Prognostic Score.
Indicates statistical significance.